FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Arrayit Corporation Stock AnalysisComprehensive stock analysis for Arrayit Corporation (ARYC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisARYC
ARYC
Arrayit Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ARYC
Home🔹Stocks🔹Arrayit Corporation

Arrayit Corporation

🇺🇸ARYC•OTC

Arrayit Corporation

🇺🇸ARYC•OTC
Market cap
$79.35K
Sentiment

Your view on ARYC

Mkt Cap
$79.35K
Sentiment
Your view
ARYC
Arrayit Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ARYC
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Arrayit Corporation

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Rene A. Schena
Headquarters
927 Thompson Place, Sunnyvale, CA, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Rene A. Schena
Headquarters
927 Thompson Place, Sunnyvale, CA, US
Description

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide.

The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states.

It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others.

The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers.

In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray.

Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies.

The company is headquartered in Sunnyvale, California.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Arrayit Corporation, and the rating behind it. ARYC last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Arrayit Corporation. Starting points for Arrayit Corporation: EPS -$0.08, beta -15.67 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Arrayit Corporation. Arrayit Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Arrayit Corporation. Trailing twelve-month EPS for Arrayit Corporation stands at -$0.08. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Arrayit Corporation. Arrayit Corporation has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Arrayit Corporation valued side by side against its closest peers. Arrayit Corporation is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Arrayit Corporation, and how their positions are changing. At a $79,348 market value, institutional positions materially move Arrayit Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Arrayit Corporation executives and directors. Shares of Arrayit Corporation have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Arrayit Corporation. Arrayit Corporation is a $79,348 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Arrayit Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Arrayit Corporation. Coverage tracks Arrayit Corporation within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BRAXF — Braxia Scientific Corp.
  • GREH — Green Rain Energy Holdings Inc.
  • JNHMF — Jack Nathan Medical Corp.
  • MEDVF — Medivolve Inc.
  • MOBO — Mobile Lads Corp.
  • PASO — Patient Access Solutions, Inc.
  • REZNF — Street Capital Inc.
  • SETO — SETO Holdings, Inc.

More Medical - Diagnostics & Research companies

  • MRPS — Microphonics, Inc.
  • MTD — Mettler-Toledo International Inc.
  • MVF.AX — Monash IVF Group Limited
  • MYGN — Myriad Genetics, Inc.
  • NDRA — ENDRA Life Sciences Inc.
  • NEO — NeoGenomics, Inc.
  • NSTM — NovelStem International Corp.
  • NTRA — Natera, Inc.
  • OCLG — Oncologix Tech, Inc.
  • OPK — OPKO Health, Inc.
  • PEB.AX — Pacific Edge Limited
  • PFGTF — Pacific Edge Limited

News

Latest Market News